{"id":"https://openalex.org/W96281018","doi":null,"title":"Bioavailability and corneal anti-inflammatory effect of topical suprofen.","display_name":"Bioavailability and corneal anti-inflammatory effect of topical suprofen.","publication_year":1986,"publication_date":"1986-04-01","ids":{"openalex":"https://openalex.org/W96281018","mag":"96281018","pmid":"https://pubmed.ncbi.nlm.nih.gov/3957583"},"language":"en","primary_location":{"id":"pmid:3957583","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3957583","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068630514","display_name":"Howard M. Leibowitz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H M Leibowitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113626668","display_name":"William J. Ryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W J Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066042003","display_name":"Allan Kupferman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kupferman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023127944","display_name":"Louis M. DeSantis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L DeSantis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5676,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.53146853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"27","issue":"4","first_page":"628","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4814000129699707,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.26170000433921814,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.15080000460147858,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/suprofen","display_name":"suprofen","score":1.0},{"id":"https://openalex.org/keywords/topical-ophthalmic-drugs","display_name":"topical ophthalmic drugs","score":0.6470000147819519},{"id":"https://openalex.org/keywords/corneal-drug-penetration","display_name":"corneal drug penetration","score":0.8309999704360962},{"id":"https://openalex.org/keywords/aqueous-humor","display_name":"aqueous humor","score":0.8410000205039978},{"id":"https://openalex.org/keywords/keratitis","display_name":"keratitis","score":0.6729999780654907},{"id":"https://openalex.org/keywords/polymorphonuclear-leukocyte-infiltration","display_name":"polymorphonuclear leukocyte infiltration","score":0.8050000071525574},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/drug-concentration","display_name":"drug concentration","score":0.4300000071525574},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.4090000092983246},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2776882836","wikidata":"https://www.wikidata.org/wiki/Q168291","display_name":"Cornea","level":2,"score":0.8613497018814087},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8065266609191895},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6065011620521545},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5868426561355591},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5082961916923523},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5073506236076355},{"id":"https://openalex.org/C2779257441","wikidata":"https://www.wikidata.org/wiki/Q2040445","display_name":"Corneal epithelium","level":3,"score":0.4728850722312927},{"id":"https://openalex.org/C2909898526","wikidata":"https://www.wikidata.org/wiki/Q757838","display_name":"Corneal inflammation","level":3,"score":0.4169090986251831},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.2401646077632904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14963069558143616}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001082","descriptor_name":"Aqueous Humor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003315","descriptor_name":"Cornea","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007634","descriptor_name":"Keratitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010666","descriptor_name":"Phenylpropionates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013496","descriptor_name":"Suprofen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013496","descriptor_name":"Suprofen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013496","descriptor_name":"Suprofen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3957583","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3957583","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},{"id":"mag:96281018","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3957583","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W81663716","https://openalex.org/W108824391","https://openalex.org/W1993204597","https://openalex.org/W2008574207","https://openalex.org/W2013352873","https://openalex.org/W2033448529","https://openalex.org/W2095358698","https://openalex.org/W2412271350","https://openalex.org/W2435785089"],"related_works":["https://openalex.org/W39673093","https://openalex.org/W2095358698","https://openalex.org/W81663716","https://openalex.org/W2759154215","https://openalex.org/W4391199802","https://openalex.org/W2018541217","https://openalex.org/W2002597879","https://openalex.org/W2003739317","https://openalex.org/W2041385662","https://openalex.org/W1997297764"],"abstract_inverted_index":{"The":[0,30,56],"bioavailability":[1,57],"in":[2,60,132,151],"rabbit":[3],"cornea":[4,37,61,97],"and":[5,53,62,117,160],"aqueous":[6,63],"humor":[7,64],"of":[8,12,23,58,67,79,84,87,95,105,114,135,163],"an":[9],"ophthalmic":[10],"formulation":[11],"suprofen,":[13],"a":[14,24,68,76,125],"nonsteroidal":[15],"anti-inflammatory":[16,154],"drug,":[17],"was":[18,71,100,143],"evaluated":[19],"following":[20,65],"topical":[21],"administration":[22,66],"single":[25],"dose":[26],"to":[27,48,90,111,168],"the":[28,35,45,80,96,103,112,120,133,139,152,158],"eye.":[29],"drug":[31],"penetrated":[32],"rapidly":[33],"into":[34,119],"uninflamed":[36],"with":[38],"intact":[39],"epithelium;":[40],"highest":[41],"levels":[42],"occurred":[43],"during":[44],"first":[46],"30":[47],"45":[49],"min":[50],"after":[51,102],"instillation":[52],"decreased":[54],"thereafter.":[55],"suprofen":[59,88,164],"1.0%":[69,161],"concentration":[70,78],"twice":[72],"that":[73,137],"produced":[74],"by":[75,157],"0.5%":[77,159],"drug.":[81],"Topical":[82],"application":[83],"multiple":[85],"doses":[86],"failed":[89],"suppress":[91],"polymorphonuclear":[92],"leukocyte":[93],"invasion":[94],"if":[98],"treatment":[99],"started":[101],"induction":[104,113],"inflammation.":[106],"Suprofen":[107],"therapy":[108],"initiated":[109],"prior":[110],"corneal":[115,153],"inflammation":[116],"maintained":[118],"post-inflammation":[121],"period":[122],"did":[123],"produce":[124],"significant":[126,145],"(P":[127,147],"less":[128],"than":[129,149],"0.01)":[130],"decrease":[131],"numbers":[134],"PMNs":[136],"invaded":[138],"inflamed":[140],"cornea.":[141],"There":[142],"no":[144],"difference":[146],"greater":[148],"0.05)":[150],"effect":[155],"achieved":[156],"concentrations":[162],"when":[165],"administered":[166],"according":[167],"this":[169],"regimen.":[170]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}